BMAL1 Monoclonal Antibody

The protein encoded by this gene is a basic helix-loop-helix protein that forms a heterodimer with CLOCK. This heterodimer binds E-box enhancer elements upstream of Period (PER1, PER2, PER3) and Cryptochrome (CRY1, CRY2) genes and activates transcription of these genes. PER and CRY proteins heterodimerize and repress their own transcription by interacting in a feedback loop with CLOCK/ARNTL complexes. Defects in this gene have been linked to infertility, problems with gluconeogenesis and lipogenesis, and altered sleep patterns. Several transcript variants encoding different isoforms have been found for this gene.

Introducing the BMAL1 Monoclonal Antibody, a cutting-edge scientific tool designed to revolutionize the field of chronobiology. This meticulously crafted antibody is specifically engineered to target and detect the BMAL1 protein, a key regulator of circadian rhythms and biological clock processes.

With its exceptional specificity and high affinity, the BMAL1 Monoclonal Antibody offers unparalleled accuracy in detecting and quantifying BMAL1 protein expression levels. This enables researchers to gain valuable insights into the intricate mechanisms governing circadian rhythms, sleep-wake cycles, and other time-dependent physiological processes.

The BMAL1 Monoclonal Antibody boasts exceptional performance across a wide range of applications, including immunohistochemistry, immunofluorescence, and Western blotting. Its robust and reliable performance ensures consistent and reproducible results, empowering researchers to delve deeper into the complexities of circadian biology.

Crafted with utmost precision and rigorously validated, this antibody guarantees exceptional quality and reliability. Its monoclonal nature ensures batch-to-batch consistency, eliminating any concerns of variability and ensuring reliable and reproducible results across experiments.

Furthermore, the BMAL1 Monoclonal Antibody is manufactured using state-of-the-art techniques and undergoes stringent quality control measures to ensure optimal performance. Its exceptional sensitivity and specificity make it an indispensable tool for researchers seeking to unravel the mysteries of circadian rhythms and their impact on human health and disease.

In summary, the BMAL1 Monoclonal Antibody represents a breakthrough in chronobiology research, offering researchers an invaluable tool to explore the intricate mechanisms governing circadian rhythms. With its exceptional specificity, reliability, and performance, this antibody is poised to revolutionize the field and drive advancements in our understanding of time-dependent biological processes.